Merck’s Covid-19 Pill Licensed to U.N.-Backed Nonprofit to Increase Global Supplies

Merck’s Covid-19 Pill Licensed to U.N.-Backed Nonprofit to Increase Global Supplies

Merck is licensing molnupiravir, an antiviral it developed with Ridgeback Biotherapeutics, to a group that will pick drugmakers to make the pill for low- and middle-income countries.

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting